Results 11 to 20 of about 4,625,876 (321)

Glial Purinergic Signaling in Neurodegeneration [PDF]

open access: yesFrontiers in Neurology, 2021
Purinergic signaling regulates neuronal and glial cell functions in the healthy CNS. In neurodegenerative diseases, purinergic signaling becomes dysregulated and can affect disease-associated phenotypes of glial cells. In this review, we discuss how cell-
Marie J. Pietrowski   +9 more
doaj   +8 more sources

Purinergic signaling: Diverse effects and therapeutic potential in cancer. [PDF]

open access: yesFront Oncol, 2023
Regardless of improved biological insights and therapeutic advances, cancer is consuming multiple lives worldwide. Cancer is a complex disease with diverse cellular, metabolic, and physiological parameters as its hallmarks.
Kaur J, Dora S.
europepmc   +3 more sources

Single-cell RNA sequencing reveals distinct transcriptional features of the purinergic signaling in mouse trigeminal ganglion

open access: yesFrontiers in Molecular Neuroscience, 2022
Trigeminal ganglion (TG) is the first station of sensory pathways in the orofacial region. The TG neurons communicate with satellite glial cells (SGCs), macrophages and other cells forming a functional unit that is responsible for processing of orofacial
Shilin Jia   +10 more
doaj   +2 more sources

Purinergic signaling in the male reproductive tract. [PDF]

open access: yesFront Endocrinol (Lausanne), 2022
Purinergic receptors are ubiquitously expressed throughout the body and they participate in the autocrine and paracrine regulation of cell function during normal physiological and pathophysiological conditions.
Belardin LB   +4 more
europepmc   +3 more sources

Purinergic Signaling in Spermatogenesis. [PDF]

open access: yesFront Endocrinol (Lausanne), 2022
Adenosine triphosphate (ATP) serves as the essential source of cellular energy. Over the last two decades, however, ATP has also attracted increasing interest as an extracellular signal that activates purinergic plasma membrane receptors of the P2 family.
Mundt N, Kenzler L, Spehr M.
europepmc   +5 more sources

Purinergic signaling: A gatekeeper of blood-brain barrier permeation. [PDF]

open access: yesFront Pharmacol, 2023
This review outlined evidence that purinergic signaling is involved in the modulation of blood-brain barrier (BBB) permeability. The functional and structural integrity of the BBB is critical for maintaining the homeostasis of the brain microenvironment.
Wang Y   +6 more
europepmc   +3 more sources

Emerging roles of purinergic signaling in anti-cancer therapy resistance

open access: yesFrontiers in Cell and Developmental Biology, 2022
Cancer is a complex disease with a rapid growing incidence and often characterized by a poor prognosis. Although impressive advances have been made in cancer treatments, resistance to therapy remains a critical obstacle for the improvement of patients ...
Michele Zanoni   +3 more
doaj   +2 more sources

Purinergic Signaling and Related Biomarkers in Depression

open access: yesBrain Sciences, 2020
It is established that purinergic signaling can shape a wide range of physiological functions, including neurotransmission and neuromodulation. The purinergic system may play a role in the pathophysiology of mood disorders, influencing neurotransmitter ...
Francesco Bartoli   +3 more
doaj   +2 more sources

Purinergic Signaling in Bone [PDF]

open access: yesJournal of Osteoporosis, 2013
In recent years, it has become apparent that extracellular nucleotides, signalling via P2 receptors, play an important role in the regulation of bone turnover. Furthermore, purinergic signalling has been associated in the pathophysiology of several bone and cartilage diseases, including osteoarthritis, rheumatoid arthritis, and osteoporosis and might ...
Niklas Rye Jørgensen   +3 more
doaj   +4 more sources

Purinergic Signaling in the Hallmarks of Cancer [PDF]

open access: yesCells, 2020
Cancer is a complex expression of an altered state of cellular differentiation associated with severe clinical repercussions. The effort to characterize this pathological entity to understand its underlying mechanisms and visualize potential therapeutic ...
A. Campos-Contreras   +2 more
semanticscholar   +5 more sources

Home - About - Disclaimer - Privacy